← Back to Search

Cannabinoid

Cannabidiol for Alcoholism

Phase 2
Waitlist Available
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-8 weeks
Awards & highlights

Summary

This trial will compare CBD to a placebo in reducing alcohol consumption for people with moderate alcohol use disorder.

Eligible Conditions
  • Alcoholism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol Dependence/Craving
Drinks per Drinking Day
Secondary outcome measures
Anxiety
Cue-reactivity
Sleep Quality
+1 more

Side effects data

From 2022 Phase 2 & 3 trial • 90 Patients • NCT04387617
38%
Tiredness
24%
Drowsiness
24%
Poor sleep
22%
Constipation
18%
Poor Appetite
16%
Dizziness
9%
Headache
7%
Diarrhea
7%
Nausea
4%
Itching
100%
80%
60%
40%
20%
0%
Study treatment Arm
CBD Oil Group
Control Group

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Broad-spectrum CannabidiolExperimental Treatment1 Intervention
150mg/day of broad-spectrum cannabidiol, containing 0%THC.
Group II: Full-spectrum CannabidiolActive Control1 Intervention
150mg/day of full-spectrum cannabidiol, containing less than 0.3%THC.
Group III: PlaceboPlacebo Group1 Intervention
150mg/day of hemp-seed oil with no cannabinoids present.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cannabidiol
2021
Completed Phase 3
~1010

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,758 Previous Clinical Trials
2,166,215 Total Patients Enrolled
12 Trials studying Alcoholism
1,671 Patients Enrolled for Alcoholism
~12 spots leftby Jul 2025